Angiotensin-II- receptor antagonists (sartans) containing a tetrazole

Sartans Art 31 - assessment report

14.2.2019 Angiotensin-II-receptor antagonists/blockers (further referred to as “sartans” or “ARBs”) are authorised in the EU as a single agent or in ...
angiotensin ii receptor antagonists sartans article referral chmp assessment report en

Angiotensin II Type 1 Receptor Blockers

antagonist of angiotensin II receptors.3–9 With saralasin it has been that angiotensin II receptor blockers would produce.

Angiotensin-II- receptor antagonists (sartans) containing a tetrazole

5.3.2021 In November 2020 the CHMP adopted an Opinion concluding that the outcome of the Article 31 referral on angiotensin-II-receptor antagonists ...
angiotensin ii receptor antagonists sartans article referral questions answers implementation en

REVIEW - Angiotensin-II receptor blockers: benefits beyond blood

3.3.2005 II receptor blocker (ARB) class of antihypertensive ... Keywords: angiotensin II receptor blockers; antihypertensive therapy; blood pressure ...
jhumanhypertension

Angiotensin-II- receptor antagonists (sartans) containing a tetrazole

17.4.2019 On 31 January 2019 EMA recommended that companies making sartan blood pressure medicines (also known as angiotensin II receptor blockers) ...
angiotensin ii receptor antagonists sartans article referral sartan medicines companies review en

Clinical pharmacokinetics of angiotensin II (AT1) receptor blockers

Angiotensin II receptor blockers (ARBs) represent a new class of effective and well tolerated orally active antihy- pertensive agents. Recent clinical trials
?origin=ppub